News
The explanation for why the valve failed is too little, too late: Boston Scientific ended global sales of the device ...
UBCO’s Dr. Hadi Mohammadi has just put his iValve heart valve through its paces—comparing its viability to other valves ...
A deep dive into the technological progress of today’s smart valves, bearings, brakes, gearboxes and actuators, and what’s next.
Boston Scientific is pulling its latest transcatheter aortic heart valve platform from the worldwide market and said it will ...
Similar to testing a car, a team of researchers at UBC Okanagan has been test-driving a number of mechanical heart valves (MHV)—and the one designed in their own lab appears to outperform the others.
2d
Medical Device Network on MSNFDA approves Abbott’s TMVR system to treat mitral valve diseaseThe US Food and Drug Administration (FDA) has granted approval for Abbott's Tendyne transcatheter mitral valve replacement ...
Net Sales at Rs 14.71 crore in March 2025 down 14.71% from Rs. 17.25 crore in March 2024. Quarterly Net Profit at Rs. 2.13 ...
The FDA approved Abbott's Tendyne minimally invasive heart replacement for mitral valve disease that could disqualify ...
Boston Scientific ends global sales of ACURATE valves and halts FDA pursuit, citing rising regulatory burdens; expects to ...
Abbott (NYSE: ABT) announced today that it received FDA approval for its Tendyne transcatheter mitral valve replacement (TMVR ...
The FDA gave the OK for the North Chicago-based medical device maker's Tendyne transcatheter mitral valve replacement.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results